283 related articles for article (PubMed ID: 11059866)
1. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
[TBL] [Abstract][Full Text] [Related]
2. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
[TBL] [Abstract][Full Text] [Related]
3. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases.
Sumida Y; Nakashima T; Yoh T; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Nakamura H; Yodoi J
Liver; 2001 Oct; 21(5):295-9. PubMed ID: 11589765
[TBL] [Abstract][Full Text] [Related]
4. Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.
Tamai T; Uto H; Takami Y; Oda K; Saishoji A; Hashiguchi M; Kumagai K; Kure T; Mawatari S; Moriuchi A; Oketani M; Ido A; Tsubouchi H
World J Gastroenterol; 2011 Nov; 17(44):4890-8. PubMed ID: 22171130
[TBL] [Abstract][Full Text] [Related]
5. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.
Mahmood S; Yamada G; Niiyama G; Kawanaka M; Togawa K; Sho M; Ito T; Sasagawa T; Okita M; Nakamura H; Yodoi J
Free Radic Res; 2003 Jul; 37(7):781-5. PubMed ID: 12911275
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Nakashima T; Sumida Y; Yoh T; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Kashima K; Nakamura H; Yodoi J
Antioxid Redox Signal; 2000; 2(4):687-94. PubMed ID: 11213474
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum level of thioredoxin in patients with hepatocellular carcinoma.
Miyazaki K; Noda N; Okada S; Hagiwara Y; Miyata M; Sakurabayashi I; Yamaguchi N; Sugimura T; Terada M; Wakasugi H
Biotherapy; 1998; 11(4):277-88. PubMed ID: 9950104
[TBL] [Abstract][Full Text] [Related]
9. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels.
Itoh Y; Morita A; Nishioji K; Narumi S; Toyama T; Daimon Y; Nakamura H; Kirishima T; Okanoue T
J Viral Hepat; 2001 Sep; 8(5):341-8. PubMed ID: 11555191
[TBL] [Abstract][Full Text] [Related]
11. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.
Sumida Y; Nakashima T; Yoh T; Furutani M; Hirohama A; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2003 Jan; 38(1):32-8. PubMed ID: 12480557
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.
Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Ohmiya M; Tani Y; Ikematsu H; Kashiwagi S
Dig Dis Sci; 1995 Aug; 40(8):1837-41. PubMed ID: 7648988
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C.
Yoshida Y; Imai Y; Sawai Y; Saito Y; Cao J; Fukuda K; Niki E
J Gastroenterol Hepatol; 2010 Jan; 25(1):107-15. PubMed ID: 19780883
[TBL] [Abstract][Full Text] [Related]
14. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
[TBL] [Abstract][Full Text] [Related]
15. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
17. Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.
Kuo WH; Chou FP; Lu SC; Chu SC; Hsieh YS
Clin Chim Acta; 2000 Apr; 294(1-2):157-68. PubMed ID: 10727681
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
19. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
Moussa YI; Plevris JN; Hayes PC
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]